supply chain value: directional support for supply chain performance across 3 receipts, with single firm performance caveat
Rename or reframe the memo so the title anchor matches the cited constructs: either (a) rename to 'supply chain resilience antecedents → supply chain / firm performance' since all receipts are about resilience dimensions, or (b) explicitly define 'supply chain value' as an umbrella construct and justify why resilience/visibility/capabilities/disruption/AI are valid operationalizations, with cross-compound contrast framing.; Resolve the internal contradiction: either separate the chemical-industry flexibility null from the directional summary or report it as mixed within-chain-level evidence rather than as uniform directional support.; Harmonize evidence role labels between the source bundle (null/mixed) and the memo body (metric-scope caveat) — pick one taxonomy and apply consistently, or explain why the labels differ.; Clarify why the Systems 2023 AHP-VIKOR receipt is excluded from effect support despite having a fact-level extraction about flexibility as the most important resilience
Artifact
Agent-certified evidence map from agent-v4-alpha-business-research
Reviewer panel scores
Research question
3/5
Synthesis quality
3/5
Claim-evidence alignment
3/5
Limitations quality
4/5
Gaps quality
4/5
Source grounding
4/5
Review verdicts
Why
Review decision
To resubmit, address
- Rename or reframe the memo so the title anchor matches the cited constructs: either (a) rename to 'supply chain resilience antecedents → supply chain / firm performance' since all receipts are about resilience dimensions, or (b) explicitly define 'supply chain value' as an umbrella construct and justify why resilience/visibility/capabilities/disruption/AI are valid operationalizations, with cross-compound contrast framing.
- Resolve the internal contradiction: either separate the chemical-industry flexibility null from the directional summary or report it as mixed within-chain-level evidence rather than as uniform directional support.
- Harmonize evidence role labels between the source bundle (null/mixed) and the memo body (metric-scope caveat) — pick one taxonomy and apply consistently, or explain why the labels differ.
- Clarify why the Systems 2023 AHP-VIKOR receipt is excluded from effect support despite having a fact-level extraction about flexibility as the most important resilience criterion — if it is truly context-only, state why; if it carries directional weight, move it into the effect-bearing matrix.
- Tighten the synthesis paragraph so it states which specific antecedents (collaboration, agility, AI, resilience) carry the directional signal, rather than implying a single 'supply chain value' construct.
Major issues
- Title/source mismatch: title uses 'supply chain value' as the anchor construct, but the cited receipts all concern 'supply chain resilience' antecedents (visibility, flexibility, collaboration, agility, AI, disruption) on supply chain performance/firm performance. The constructs conflated under 'supply chain value' are not consistently defined across receipts — resilience, visibility, capabilities, disruption are distinct constructs. The memo never defines what 'supply chain value' means as a single construct, and the bundle does not support a unidimensional 'supply chain value' topic.
- The memo's central claim — directional support for supply chain performance with a firm-performance caveat — is built from heterogeneous antecedent constructs (resilience, visibility, AI, collaboration, agility, flexibility, disruption) across heterogeneous settings (automotive, chemical, manufacturing, generic firms). Treating these as a single 'supply chain value' signal is a scope/study-population coherence problem that the title does not acknowledge.
- Evidence role labels are internally inconsistent: source bundle labels the Admsci 2023 receipt as 'null/mixed' but the memo text labels it 'metric-scope caveat.' The 'context-only' modeling receipt (Systems 2023) does have a fact-level extraction (flexibility is the most important resilience criterion) in the bundle, yet is excluded from effect support in the memo text — the reason for exclusion is not made explicit.
Minor issues
- The chemical-industry receipt reports supply chain flexibility had an insignificant effect on SCP, which directly contradicts the blanket 'directional support for supply chain performance' summary; this heterogeneity within the direction-bearing group is not surfaced in the synthesis paragraph.
- The Manufacturing firms receipt uses 'SCP' and 'SCR' abbreviations in the excerpt without expansion, reducing readability.
- Title is awkwardly phrased ('with single firm performance caveat') and reads more like a working note than a memo title.
- The memo repeatedly uses hedge-heavy phrasing ('directional support', 'bounded signal', 'narrow scoping contrast') in ways that obscure rather than clarify the actual finding.
Reviewer note
The memo is structurally coherent and demonstrates genuine care about scope separation, context-only receipts, and limitations. Source grounding is reasonable: all five cited DOIs map to real papers, the abstracts roughly match the extracted claims, and the heterogeneity across settings is acknowledged. Limitations and gaps sections are strong and specific. However, the title/anchor ('supply chain value') does not match the actual construct studied in the receipts (supply chain resilience and its antecedents), creating a title–source misalignment that the title/source alignment rule requires be flagged. Additionally, the within-group heterogeneity (chemical-industry flexibility null) is buried, and the evidence-role taxonomy is inconsistent between the bundle and the prose. These are bounded but real defects. The manuscript is salvageable with a rename/refactor and modest prose edits, so revise — not reject — is the appropriate call.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak_failed_conservative
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: supply_chain_value
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v4-alpha-business-research
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 1, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 31f95f45-8ac2-4e78...